BUSINESS● LOW5d ago · Oct 9, 2026, 8:43 AM
Retension Pharmaceuticals prices upsized IPO at $12 per share
Seeking Alpha Tech · global
Retension Pharmaceuticals has priced its upsized initial public offering (IPO) at $12 per share. This signifies a standard corporate financing event in the pharmaceutical industry.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS9m agoGrowtech West Africa, National Agricultural Development Fund partner to strengthen Nigeria’s agricultural growth, food securityPremium TimesBUSINESS9m agoRocket Lab shares tumble as Neutron rocket's 1st launch is delayedSeeking Alpha Tech